Correlation Between Galapagos and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Galapagos and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galapagos and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Galapagos NV ADR and Spero Therapeutics, you can compare the effects of market volatilities on Galapagos and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galapagos with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galapagos and Spero Therapeutics.
Diversification Opportunities for Galapagos and Spero Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Galapagos and Spero is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Galapagos NV ADR and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Galapagos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galapagos NV ADR are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Galapagos i.e., Galapagos and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Galapagos and Spero Therapeutics
Given the investment horizon of 90 days Galapagos NV ADR is expected to generate 0.91 times more return on investment than Spero Therapeutics. However, Galapagos NV ADR is 1.1 times less risky than Spero Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 2,876 in Galapagos NV ADR on August 28, 2024 and sell it today you would lose (145.00) from holding Galapagos NV ADR or give up 5.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Galapagos NV ADR vs. Spero Therapeutics
Performance |
| Timeline |
| Galapagos NV ADR |
| Spero Therapeutics |
Galapagos and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Galapagos and Spero Therapeutics
The main advantage of trading using opposite Galapagos and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galapagos position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Galapagos vs. CytomX Therapeutics | Galapagos vs. Spero Therapeutics | Galapagos vs. Instil Bio | Galapagos vs. NextCure |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |